Hatteras backs $3 million seed round for UNC spin-out with stem-cell platform
Date Published:
A Triangle spin-out company looking to develop its stem-cell technology has wrapped up a $3.1 million seed investment led by…
Life Sciences
LabCorp gets FDA approval for pooled Covid-19 testing that increases capacity, saves supplies
Date Published:
Seeking to improve turnaround times for Covid-19 testing, Burlington-based LabCorp (NYSE: LH) has received emergency approval from the U.S. Food…
IQVIA Initiative Gives COVID-19 Researchers Free Access to Global Data
Date Published:
Research Triangle Park-based contract research giant IQVIA has launched a program that waives licensing and access fees for approved academic…
HIV prevention drug backed by RTI International research takes step toward federal regulation
Date Published:
A technology for HIV prevention that’s been studied for years by researchers in the Triangle has taken a big leap…
Trump visit to highlight Triangle firm’s role in producing possible COVID-19 vaccine
Date Published:
RESEARCH TRIANGLE PARK – North Carolina’s global leadership in biomanufacturing has drawn a major spotlight with a White House announcement…
UNC, Baylor researchers report first successful lymphoma treatment using a cell therapy
Date Published:
CHAPEL HILL – CAR-T cell therapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been used to…
Trump to see the ‘magic’ behind Covid-19 vaccine effort during Morrisville visit
Date Published:
The purpose of President Donald Trump’s upcoming visit to a Triangle biotech is simple: To see where the ‘magic’ happens,…
UNC-Chapel Hill team develops digital tool to fight elder abuse
Date Published:
CHAPEL HILL – UNC-Chapel Hill faculty member Meredith Smith works with North Carolina’s clerks of superior court. In their judicial…
Triangle firm lands deal worth up to $310M for breast cancer treatment
Date Published:
RESEARCH TRIANGLE PARK – G1 Therapeutics has landed a licensing del worth up to $310 million not counting royalties for…